Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Wolbers

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Statistics in Medicine|May 4, 2007
Comments on 'Analysing and interpreting competing risk data' (original article and author's reply)Marcel Wolbers, Michael Koller
Statistics in Medicine|October 27, 2016
Weighted analysis of composite endpoints with simultaneous inference for flexible weight constraintsAnh Nguyen Duc, Marcel Wolbers
Open Forum Infectious Diseases|June 26, 2015
Limitation of the Benefit of Amphotericin-Flucytosine Combination Therapy in Patients With Lower Conscious Level: An Ecological Fallacy?Marcel Wolbers, Jeremy N Day
Statistics in Medicine|May 26, 2017
Smooth semi-nonparametric (SNP) estimation of the cumulative incidence functionAnh Nguyen Duc, Marcel Wolbers
Statistics in Medicine|June 24, 2008
Two-stage randomization designs in drug developmentMarcel Wolbers, Jeffrey D Helterbrand
The New England Journal of Medicine|October 5, 2017
Itraconazole or Amphotericin B for TalaromycosisThuy Le, Guy Thwaites, Marcel Wolbers
The New England Journal of Medicine|July 14, 2016
Dexamethasone in Cryptococcal MeningitisJustin Beardsley, Marcel Wolbers, Jeremy N Day, et al.
JAMA|November 4, 2010
2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA PanelHeiner C Bucher, Marcel Wolbers, Kholoud Porter
Journal of Biopharmaceutical Statistics|April 10, 2026
Bayesian analysis of the causal reference-based model for missing data in clinical trialsBrendah Nansereko, Marcel Wolbers, James Carpenter, et al.
Pharmaceutical Statistics|September 2, 2020
A pragmatic adaptive enrichment design for selecting the right target population for cancer immunotherapiesAnh Nguyen Duc, Dominik Heinzmann, Claude Berge, et al.
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Statistics in Medicine|May 4, 2007
Comments on 'Analysing and interpreting competing risk data' (original article and author's reply)Marcel Wolbers, Michael Koller
Statistics in Medicine|October 27, 2016
Weighted analysis of composite endpoints with simultaneous inference for flexible weight constraintsAnh Nguyen Duc, Marcel Wolbers
Open Forum Infectious Diseases|June 26, 2015
Limitation of the Benefit of Amphotericin-Flucytosine Combination Therapy in Patients With Lower Conscious Level: An Ecological Fallacy?Marcel Wolbers, Jeremy N Day
Statistics in Medicine|May 26, 2017
Smooth semi-nonparametric (SNP) estimation of the cumulative incidence functionAnh Nguyen Duc, Marcel Wolbers
Statistics in Medicine|June 24, 2008
Two-stage randomization designs in drug developmentMarcel Wolbers, Jeffrey D Helterbrand
The New England Journal of Medicine|October 5, 2017
Itraconazole or Amphotericin B for TalaromycosisThuy Le, Guy Thwaites, Marcel Wolbers
The New England Journal of Medicine|July 14, 2016
Dexamethasone in Cryptococcal MeningitisJustin Beardsley, Marcel Wolbers, Jeremy N Day, et al.
JAMA|November 4, 2010
2010 guidelines for antiretroviral treatment of HIV from the International AIDS Society-USA PanelHeiner C Bucher, Marcel Wolbers, Kholoud Porter
Journal of Biopharmaceutical Statistics|April 10, 2026
Bayesian analysis of the causal reference-based model for missing data in clinical trialsBrendah Nansereko, Marcel Wolbers, James Carpenter, et al.
Pharmaceutical Statistics|September 2, 2020
A pragmatic adaptive enrichment design for selecting the right target population for cancer immunotherapiesAnh Nguyen Duc, Dominik Heinzmann, Claude Berge, et al.
Pageof 14